SOFIXA

Third-Generation Cephalosporin for Bacterial Infections

Anti-infective Brand

SOFIXA

SOFIXA contains cefixime, an orally active third-generation cephalosporin with bactericidal activity against susceptible bacterial pathogens. It is indicated for the treatment of selected respiratory and urinary tract infections.

Therapeutic category

Anti-infective

Dosage form

Capsules

Strengths Available

200mg, 400mg

Pack size

Pack of 1x10 Capsules

Therapeutic Indications

  • SOFIXA is indicated for the treatment of susceptible bacterial infections of the upper and lower respiratory tracts and urinary tract.
Packshot not available

Brand Name

SOFIXA

Product Name

SOFIXA 200

Generic Name

Cefixime Capsules 200mg

Dosage Form

Capsules

Pack Size

Pack of 1x10 Capsules

SOFIXA 200

Cefixime Capsules 200mg

Therapeutic Indication

SOFIXA is indicated for the treatment of susceptible bacterial infections of the upper and lower respiratory tracts and urinary tract.

Dosage and Method of Administration

Adults and children over 10 years:

  • 100–200 mg daily, as a single dose or in two divided doses, depending on the severity of infection.

Mode of Administration

For oral use only.

Packshot not available

Brand Name

SOFIXA

Product Name

SOFIXA 400

Generic Name

Cefixime Capsules 400mg

Dosage Form

Capsules

Pack Size

Pack of 1x10 Capsules

SOFIXA 400

Cefixime Capsules 400mg

Therapeutic Indication

SOFIXA is indicated for the treatment of susceptible bacterial infections of the upper and lower respiratory tracts and urinary tract.

Dosage and Method of Administration

Adults and children over 10 years:

100–200 mg daily, as a single dose or in two divided doses, depending on the severity of infection.

Mode of Administration

For oral use only.